To investigate CBAVD at the molecular level in Iran, Radpour and colleagues have characterized the mutations in the CFTR gene in patients with this condition; none had clinical manifestations of cystic fibrosis (CF). This evidence concerns the gene CFTR and congenital bilateral aplasia of vas deferens from CFTR mutation.